Share Prices & Company Research

Stockbroking

Hikma Pharmaceuticals

Current Price 1992.00p Bid 1991.00p Ask 1993.00p Change 0.94%
Last Updated: 24/12/2024 18:49. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.

Financial Highlights Year Ended 31/12/2023

Revenue
£2,875.00m
Operating Profit/Loss
£367.00m
Dividend yield (%)
3.20
Total dividend for year
$n/a
Dividend cover
3.10
P/E Ratio
10.00
More Financials

Key Personnel

Mr Riad Mishlawi
Chief Executive Officer
Mr Said Darwazah
Executive Chairman
Mr Mazen Darwazah
Executive Vice Chairman
Mr Douglas Hurt
Independent Non-Executive Director
Mr John J. Castellani
Independent Non-Executive Director
Mrs Cynthia Schwalm
Independent Non-Executive Director
Ms Deneen Vojta
Independent Non-Executive Director
Ms Laura Balan Balan
Independent Non-Executive Director
Ms Mary (Nina) Henderson
Independent Non-Executive Director
Ms Victoria Hull
Independent Non-Executive Director
Mr Ali Al-Husry
Non-Executive Director

Stock Details

EPIC
HIKL
ISIN
GB00B0LCW083
Shares in Issue
199.39m
Market cap
£3,971.75m

Analyst Views (1)

Strong Buy
 
0%
Buy
 
100.00%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
1,992.00p
Bid Price
1,991.00p
Ask Price
1,993.00p
Volume
9,916
Change Today
18.50p
% Change Today
0.94%
Open
1,988.00p
Previous Close
1,992.00p
Intraday High
1,997.00p
Intraday Low
1,982.00p
52 Week High
2,087.00p
52 Week Low
1,771.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

More Charts

Income Statement

Year End Date
31 Dec 2023
31 Dec 2022
 
$ (M)
$ (M)
Continuing Operations
Revenue
2,875.00
2,517.00
Operating Profit/Loss
367.00
282.00
Net Interest
-88.00
-52.00
Pre-Tax Profit
281.00
233.00
Profit After Tax from continuing operations
192.00
191.00
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
192.00
191.00
Attributable to:
Equity Holders of Parent Company
190.00
188.00
Minority Interests
2.00
3.00
Total Dividend Paid
$n/a
$n/a
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
31 Dec 2023
31 Dec 2022
Basic
86.00c
84.00c
Diluted
85.00c
84.00c
Adjusted
223.00c
181.00c
Dividend per Share
$n/a
$n/a

Assets

Year End Date
31 Dec 2023
31 Dec 2022
 
$ (M)
$ (M)
Non-Current Assets
Property, Plant & Equipment
1,141.00
1,081.00
Intangible Assets
1,100.00
1,124.00
Investment Properties
n/a
n/a
Investments
10.00
10.00
Other Financial Assets
103.00
65.00
Other Non-Current Assets
226.00
192.00
Current Assets
Inventories
891.00
776.00
Trade & Other Receivables
873.00
841.00
Cash at Bank & In Hand
205.00
270.00
Current Asset Investments
n/a
n/a
Other Current Assets
131.00
112.00
Other Assets
n/a
n/a
Total Assets
4,680.00
4,471.00

Liabilities

Year End Date
31 Dec 2023
31 Dec 2022
 
$ (M)
$ (M)
Current Liabilities
Borrowings
161.00
148.00
Other Current Liabilities
1,178.00
929.00
Total Current Liabilities
1,339.00
1,077.00
Non-Current Liabilities
Borrowings
1,030.00
1,135.00
Provisions
32.00
19.00
Other Non-Current Liabilities
70.00
92.00
Total Non-Current Liabilities
1,132.00
1,246.00
Other Liabilities
n/a
n/a
Total Liabilities
2,471.00
2,323.00

Net Assets

Year End Date
31 Dec 2023
31 Dec 2022
 
$ (M)
$ (M)
Net Assets
2,209.00
2,148.00

Capital & Reserves

Year End Date
31 Dec 2023
31 Dec 2022
 
$ (M)
$ (M)
Share Capital
40.00
40.00
Share Premium Account
282.00
282.00
Other Reserves
-282.00
-279.00
Retained Earnings
2,158.00
2,092.00
Shareholders Funds
2,198.00
2,135.00
Minority Interests/Other Equity
11.00
13.00
Total Equity
2,209.00
2,148.00

Dividend History

Type
Ex-Dividend Date
Payment Date
Payment
Interim
15 Aug 2024
20 Sep 2024
32.00¢
Final
21 Mar 2024
03 May 2024
47.00¢
Interim
10 Aug 2023
15 Sep 2023
25.00¢
Final
23 Mar 2023
05 May 2023
37.00¢
Interim
18 Aug 2022
20 Sep 2022
19.00¢
Interim
18 Aug 2022
20 Sep 2022
19.00¢
Final
17 Mar 2022
28 Apr 2022
36.00¢
Final
17 Mar 2022
28 Apr 2022
36.00¢
Interim
19 Aug 2021
20 Sep 2021
18.00¢
Interim
19 Aug 2021
20 Sep 2021
18.00¢
Final
18 Mar 2021
26 Apr 2021
34.00¢
Interim
20 Aug 2020
21 Sep 2020
16.00¢
Final
19 Mar 2020
07 May 2020
30.00¢
Interim
22 Aug 2019
23 Sep 2019
14.00¢
Final
04 Apr 2019
22 May 2019
26.00¢
Interim
23 Aug 2018
21 Sep 2018
12.00¢
Final
05 Apr 2018
24 May 2018
23.00¢
Interim
24 Aug 2017
22 Sep 2017
11.00¢
Final
06 Apr 2017
25 May 2017
22.00¢
Interim
01 Sep 2016
30 Sep 2016
11.00¢
Final
07 Apr 2016
19 May 2016
21.00¢
Interim
27 Aug 2015
25 Sep 2015
11.00¢
Special
16 Apr 2015
21 May 2015
6.00¢
Special
16 Apr 2015
21 May 2015
6.00¢
Special
16 Apr 2015
21 May 2015
6.00¢
Special
16 Apr 2015
21 May 2015
6.00¢

Dividend Metrics

Year End Date
31 Dec 2023
31 Dec 2022
Dividend growth
28.57%
3.70%
Dividend yield
3.20%
2.90%
Dividend cover
3.10
3.23


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.